Published in Sci Rep on September 08, 2016
Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling. Sci Rep (2017) 0.77
A Proteomic Analysis of the Malignant Mesothelioma Secretome Using iTRAQ. Cancer Genomics Proteomics (2017) 0.75
Diagnostic and prognostic biomarkers for malignant mesothelioma: an update. Transl Lung Cancer Res (2017) 0.75
Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem (2002) 35.30
Genes that mediate breast cancer metastasis to lung. Nature (2005) 19.85
Microenvironmental regulation of metastasis. Nat Rev Cancer (2008) 15.76
Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer (2009) 14.17
Rab GTPases as coordinators of vesicle traffic. Nat Rev Mol Cell Biol (2009) 13.01
Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET. Nat Med (2012) 11.14
Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer (2004) 8.06
Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell (2000) 6.70
Targeting MET in cancer: rationale and progress. Nat Rev Cancer (2012) 6.43
Interpretation of shotgun proteomic data: the protein inference problem. Mol Cell Proteomics (2005) 6.28
A chromatin remodelling complex involved in transcription and DNA processing. Nature (2000) 5.77
Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat Med (2001) 5.71
The metastatic niche: adapting the foreign soil. Nat Rev Cancer (2009) 5.28
Malignant effusions and immunogenic tumour-derived exosomes. Lancet (2002) 4.91
Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov (2013) 4.35
Mesothelin: a new target for immunotherapy. Clin Cancer Res (2004) 4.30
Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell (2012) 4.29
Exosomes: proteomic insights and diagnostic potential. Expert Rev Proteomics (2009) 4.27
Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med (2011) 4.25
Hallmarks of cancer: interactions with the tumor stroma. Exp Cell Res (2010) 4.15
Proteomic and biochemical analyses of human B cell-derived exosomes. Potential implications for their function and multivesicular body formation. J Biol Chem (2003) 4.14
Tumour exosome integrins determine organotropic metastasis. Nature (2015) 4.09
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver. Nat Cell Biol (2015) 4.08
Microvesicles released from human renal cancer stem cells stimulate angiogenesis and formation of lung premetastatic niche. Cancer Res (2011) 3.50
Regulation of immune responses by extracellular vesicles. Nat Rev Immunol (2014) 3.24
Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol (2012) 3.18
Human tumor-derived exosomes selectively impair lymphocyte responses to interleukin-2. Cancer Res (2007) 3.07
Mesothelin-family proteins and diagnosis of mesothelioma. Lancet (2003) 2.98
Migratory neighbors and distant invaders: tumor-associated niche cells. Genes Dev (2008) 2.95
Cancer exosomes perform cell-independent microRNA biogenesis and promote tumorigenesis. Cancer Cell (2014) 2.90
The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts. Semin Cancer Biol (2011) 2.83
Regulation of secretory vesicle traffic by Rab small GTPases. Cell Mol Life Sci (2008) 2.71
Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development (2002) 2.68
Exosomes mediate the cell-to-cell transmission of IFN-α-induced antiviral activity. Nat Immunol (2013) 2.64
Antigen spreading contributes to MAGE vaccination-induced regression of melanoma metastases. Cancer Res (2011) 2.63
Malignant mesothelioma: facts, myths, and hypotheses. J Cell Physiol (2012) 2.56
Human tumor-derived exosomes down-modulate NKG2D expression. J Immunol (2008) 2.53
Comparison of ultracentrifugation, density gradient separation, and immunoaffinity capture methods for isolating human colon cancer cell line LIM1863-derived exosomes. Methods (2012) 2.46
Proteomic analysis of exosomes isolated from human malignant pleural effusions. Am J Respir Cell Mol Biol (2004) 2.44
The cell biology of thrombospondin-1. Matrix Biol (2000) 2.41
Milk fat globule-EGF factor 8/lactadherin plays a crucial role in maintenance and repair of murine intestinal epithelium. J Clin Invest (2007) 2.40
Accurate and sensitive peptide identification with Mascot Percolator. J Proteome Res (2009) 2.25
Lactadherin promotes VEGF-dependent neovascularization. Nat Med (2005) 2.19
Annexin 1: the new face of an old molecule. FASEB J (2007) 2.16
Proteomic analysis of exosomes secreted by human mesothelioma cells. Am J Pathol (2004) 2.13
Effectiveness of mesothelin family proteins and osteopontin for malignant mesothelioma. Eur Respir J (2012) 2.08
Tumor-associated macrophages regulate tumorigenicity and anticancer drug responses of cancer stem/initiating cells. Proc Natl Acad Sci U S A (2011) 2.08
Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients. Clin Cancer Res (2005) 2.05
Proteomics analysis of bladder cancer exosomes. Mol Cell Proteomics (2010) 2.04
Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation. Cancer Res (2010) 2.02
Hypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomes. Mol Cell Proteomics (2010) 1.97
Identification of mouse sperm SED1, a bimotif EGF repeat and discoidin-domain protein involved in sperm-egg binding. Cell (2003) 1.88
Glucose catabolism in cancer cells. The type II hexokinase promoter contains functionally active response elements for the tumor suppressor p53. J Biol Chem (1997) 1.83
CD44v6 dependence of premetastatic niche preparation by exosomes. Neoplasia (2009) 1.80
Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinoma. Pathol Int (2007) 1.78
Purification, characterization and biological significance of tumor-derived exosomes. Anticancer Res (2005) 1.77
A systematic review of humoral immune responses against tumor antigens. Cancer Immunol Immunother (2009) 1.75
Inflammation-based prognostic indices in malignant pleural mesothelioma. J Thorac Oncol (2012) 1.70
CD70: a new tumor specific biomarker for renal cell carcinoma. J Urol (2005) 1.67
The transferrin receptor and the targeted delivery of therapeutic agents against cancer. Biochim Biophys Acta (2011) 1.64
Prospects for exosomes in immunotherapy of cancer. J Cell Mol Med (2006) 1.63
Supramolecular complexes of MHC class I, MHC class II, CD20, and tetraspan molecules (CD53, CD81, and CD82) at the surface of a B cell line JY. J Immunol (1996) 1.63
Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells. Sci Signal (2014) 1.62
RVB1/RVB2: running rings around molecular biology. Mol Cell (2009) 1.62
α-Enolase: a promising therapeutic and diagnostic tumor target. FEBS J (2011) 1.60
Serum mesothelin for diagnosing malignant pleural mesothelioma: an individual patient data meta-analysis. J Clin Oncol (2012) 1.59
Emerging role of extracellular vesicles in inflammatory diseases. Nat Rev Rheumatol (2014) 1.47
Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components. Proteomics (2013) 1.46
Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids. Mol Cell Proteomics (2012) 1.44
Dendritic cell-derived exosomes for cancer immunotherapy: what's next? Cancer Res (2010) 1.43
Glypican-1 modulates the angiogenic and metastatic potential of human and mouse cancer cells. J Clin Invest (2008) 1.43
Human glucose-6-phosphate dehydrogenase (G6PD) gene transforms NIH 3T3 cells and induces tumors in nude mice. Int J Cancer (2000) 1.42
Regulation of cell structure and function by actin-binding proteins: villin's perspective. FEBS Lett (2008) 1.40
Gastric cancer exosomes promote tumour cell proliferation through PI3K/Akt and MAPK/ERK activation. Dig Liver Dis (2009) 1.39
MHC class II-associated proteins in B-cell exosomes and potential functional implications for exosome biogenesis. Immunol Cell Biol (2010) 1.37
Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: a role for activated fibroblasts and CX3CL1-CX3CR1 axis. Cancer Res (2009) 1.35
Extracellular vesicles: emerging targets for cancer therapy. Trends Mol Med (2014) 1.35
Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes. Oncogene (2014) 1.33
The metastatic niche and stromal progression. Cancer Metastasis Rev (2012) 1.30
Therapeutic applications of extracellular vesicles: clinical promise and open questions. Annu Rev Pharmacol Toxicol (2014) 1.29
Soluble mesothelin-related peptide level elevation in mesothelioma serum and pleural effusions. Ann Thorac Surg (2008) 1.26
Mesothelin overexpression promotes mesothelioma cell invasion and MMP-9 secretion in an orthotopic mouse model and in epithelioid pleural mesothelioma patients. Clin Cancer Res (2012) 1.25
Structural mechanisms for regulation of membrane traffic by rab GTPases. Traffic (2009) 1.25
Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool. PLoS One (2012) 1.24
Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization. Proteomics (2006) 1.24
Identification of glypican-3 as a novel tumor marker for melanoma. Clin Cancer Res (2004) 1.22
The emerging role of extracellular vesicles as biomarkers for urogenital cancers. Nat Rev Urol (2014) 1.22
Extracellular vesicles from neural stem cells transfer IFN-γ via Ifngr1 to activate Stat1 signaling in target cells. Mol Cell (2014) 1.22
Glypican-1 is frequently overexpressed in human gliomas and enhances FGF-2 signaling in glioma cells. Am J Pathol (2006) 1.21
Exosomes and their roles in immune regulation and cancer. Semin Cell Dev Biol (2015) 1.18
Multidrug resistance markers P-glycoprotein, multidrug resistance protein 1, and lung resistance protein in non-small cell lung cancer: prognostic implications. J Cancer Res Clin Oncol (2005) 1.18
Microtubules and their role in cellular stress in cancer. Front Oncol (2014) 1.15
Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients. Cancer Immunol Immunother (2011) 1.12
S100A11, an dual mediator for growth regulation of human keratinocytes. Mol Biol Cell (2007) 1.11
Gene expression profiling of malignant mesothelioma. Clin Cancer Res (2003) 1.10
Exosomes: a new delivery system for tumor antigens in cancer immunotherapy. Int J Cancer (2005) 1.10
A protocol for exosome isolation and characterization: evaluation of ultracentrifugation, density-gradient separation, and immunoaffinity capture methods. Methods Mol Biol (2015) 1.09
Extracellular vesicles - biomarkers and effectors of the cellular interactome in cancer. Front Pharmacol (2013) 1.09
Angiogenic cytokines in mesothelioma: a study of VEGF, FGF-1 and -2, and TGF beta expression. J Pathol (1999) 1.09
Immunohistochemical diagnosis of epithelioid mesothelioma: an update. Arch Pathol Lab Med (2005) 1.07
Extracellular vesicles: their role in cancer biology and epithelial-mesenchymal transition. Biochem J (2017) 0.76
Distinct temporal changes in host cell lncRNA expression during the course of an adenovirus infection. Virology (2016) 0.76
Modulating the endometrial epithelial proteome and secretome in preparation for pregnancy: The role of ovarian steroid and pregnancy hormones. J Proteomics (2016) 0.76
Transformed MDCK cells secrete elevated MMP1 that generates LAMA5 fragments promoting endothelial cell angiogenesis. Sci Rep (2016) 0.75
Data on the expression of cellular lncRNAs in human adenovirus infected cells. Data Brief (2016) 0.75